Pharma

Researchers in a lab using an iPad.
By  Emily Olsen 01:30 pm September 21, 2022
EHR data company nference on Wednesday launched its real-world evidence generation platform and expanded its existing partnership with the Mayo Clinic.  The platform, dubbed nSights, collects de-identified patient clinical data from academic medical centers, including clinical notes, radiology results, lab tests and electrocardiograms. The company said it will eventually add digital pathology and...
A pharmacist pulling a medication off a shelf.
By  Emily Olsen 01:45 pm September 19, 2022
Transcarent, a healthcare platform for self-insured employers, announced Monday it would expand into the pharmacy benefit space. The new offering, called Transcarent Pharmacy Care, will allow members to search for the lowest-cost drug option and compare prices across pharmacies. They can also transfer their prescription within Transcarent's app and access 24/7 support if needed. The company said...
A Tasso blood collection device.
By  Emily Olsen 12:07 pm September 14, 2022
Tasso received FDA 510(k) clearance for its patch-like blood collection device, the Tasso+. The device includes a lancet, which adheres to the arm, that connects to a test tube for collection. After users rub their arm or use a heat pack and sanitize the test site, they press a button on the front of the device to begin drawing capillary blood. Then the tube can be removed and sent to a lab for...
Withings' Body Pro smart scale and its BPM Connect Pro blood pressure monitor
By  Emily Olsen 10:54 am July 21, 2022
Medable is partnering with Withings Health Solutions to use the company's connected devices for decentralized clinical trials.  The collaboration will allow Withings' tools for remote monitoring, like connected scales, blood pressure monitors and sleep-tracking mats, to collect patient data and integrate with Medable's clinical trial platform.  "As the industry leader in plug-and-play connected...
Woman checking glucose level with a remote sensor and mobile phone.
By  Emily Olsen 10:27 am July 18, 2022
The Digital Medicine Society (DiMe) on Monday revealed four toolkits to help healthcare and life science organizations use data from sensors like wearables and remote patient monitoring systems at scale.  The four toolkits are based on resources derived from the society's Sensor Data Integrations project, which includes organizations like Amazon Web Services, Oracle, the Moffitt Cancer Center,...
Kaiku Health CEO and cofounder Lauri Sippola
By  Emily Olsen 11:10 am May 10, 2022
Digital cancer care company Kaiku Health has entered into a strategic partnership with pharma and diagnostics giant Roche to offer Kaiku's tools for symptom management and support to clinics and patients. Finnish-born Kaiku provides a digital platform where patients can input their symptoms as they undergo cancer treatment, receive feedback for lower-acuity concerns and keep the care team...
Businesspeople shaking hands
By  Emily Olsen 01:04 pm May 5, 2022
Prescription digital therapeutics startup MedRhythms has entered into a licensing agreement with Biogen to develop and commercialize its MR-004 product, which aims to improve mobility for people with multiple sclerosis (MS). Under the deal, MedRhythms would receive a $3 million upfront payment from Biogen, with the potential to earn up to $117.5 million if certain development and commercial...
Researchers in a lab
By  Laura Lovett 01:53 pm April 4, 2022
The Digital Medicine Society (DiMe) teamed up with a slew of pharma giants and payers to launch a digital endpoints toolkit for stakeholders. The open-access toolkit, which came from a partnership between DiMe, Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer and Savvy Co-op, gives payers a road map for including digital endpoints in reimbursement for new drugs. Dubbed the 3Ps toolkit...
Clinical trials
By  Laura Lovett 10:33 am March 17, 2022
ORLANDO, Fla. – While technology continues to propel clinical trials, research in the U.S. still lacks accurate representation of the country.  "What we know is that race and ethnicity are social constructs and are not dependent on our genes," Jennifer Jones-McMeans, divisional vice president of global clinical affairs for Abbott’s vascular business, said during a HIMSS22 session. "When we look...